Prevalence of Helicobacter pylori resistance to metronidazole, clarithromycin, amoxycillin, tetracycline and trovafloxacin in The Netherlands.
about
Tetracycline antibiotics: mode of action, applications, molecular biology, and epidemiology of bacterial resistanceH pylori antibiotic resistance: prevalence, importance, and advances in testingAnalysis of antimicrobial susceptibility and virulence factors in Helicobacter pylori clinical isolatesPrevalence of Primary Antimicrobial Resistance of H. pylori in Turkey: A Systematic Review.Impact of clarithromycin resistance on eradication of Helicobacter pylori in infected adultsRegional differences in metronidazole resistance and increasing clarithromycin resistance among Helicobacter pylori isolates from JapanNew site of modification of 23S rRNA associated with clarithromycin resistance of Helicobacter pylori clinical isolatesEfficacy of serology driven "test and treat strategy" for eradication of H. pylori in patients with rheumatic disease in the Netherlands.High-level beta-lactam resistance associated with acquired multidrug resistance in Helicobacter pylori.In Vitro Activity of 2-methoxy-1,4-naphthoquinone and Stigmasta-7,22-diene-3β-ol from Impatiens balsamina L. against Multiple Antibiotic-Resistant Helicobacter pyloriHelicobacter pylori antibiotic resistance in Iran.The incidence of primary antibiotic resistance of Helicobacter pylori in VietnamEffective regimens for the treatment of Helicobacter pylori infection.Antimicrobial susceptibility and resistance patterns among Helicobacter pylori strains from The Gambia, West Africa.Metronidazole-resistant Helicobacter pylori is more prevalent in patients with nonulcer dyspepsia than in peptic ulcer patients in a multiethnic Asian populationAntibiotics resistance rate of Helicobacter pylori in BhutanEfficacy of two triple eradication regimens in children with Helicobacter pylori infection.Complete Genome Sequences of Helicobacter pylori Clarithromycin-Resistant Strains.Antimicrobial susceptibility and mutations involved in clarithromycin resistance in Helicobacter pylori isolates from patients in the western central region of Colombia.Review article: the global emergence of Helicobacter pylori antibiotic resistance.How antibiotic resistances could change Helicobacter pylori treatment: A matter of geography?Antimicrobial susceptibility of Helicobacter pylori strains isolated in BangladeshReview article: the effectiveness of standard triple therapy for Helicobacter pylori has not changed over the last decade, but it is not good enough.Helicobacter pylori eradication in Western Australia using novel quadruple therapy combinations.Fluoroquinolone-based protocols for eradication of Helicobacter pyloriTreatment of Helicobacter pylori infection: meeting the challenge of antimicrobial resistance.Antibiotic susceptibility, heteroresistance, and updated treatment strategies in Helicobacter pylori infection.Mutations of the Helicobacter pylori genes rdxA and pbp1 cause resistance against metronidazole and amoxicillin.16S rRNA mutation-mediated tetracycline resistance in Helicobacter pylori.Emergence of tetracycline resistance in Helicobacter pylori: multiple mutational changes in 16S ribosomal DNA and other genetic loci.T2182C mutation in 23S rRNA is associated with clarithromycin resistance in Helicobacter pylori isolates obtained in Bangladesh.Single and double mutations in gyrA but not in gyrB are associated with low- and high-level fluoroquinolone resistance in Helicobacter pylori.Aerobic culture of methanogenic archaea without an external source of hydrogen.Geographical difference in antimicrobial resistance pattern of Helicobacter pylori clinical isolates from Indian patients: Multicentric study.Quinolone resistance in Helicobacter pylori isolates in Germany.In vitro activity of a novel antimicrobial agent, TG44, for treatment of Helicobacter pylori infection.Helicobacter pylori and antibiotic resistance.Efficacy of two rabeprazole/gatifloxacin-based triple therapies for Helicobacter pylori infection.Increased primary resistance to recommended antibiotics negatively affects Helicobacter pylori eradication.Emergence of clarithromycin-resistant Helicobacter pylori (CRHP) with a high prevalence in children compared with their parents.
P2860
Q24548472-54C1E158-9DD7-40DB-96D2-F57F5C813412Q24685864-F205A750-7E6F-4EDA-9D09-39449AA7CDEBQ24798919-537172B3-D5BB-4B1C-9D4D-87682F4AEC82Q30252088-A254947B-969E-40D6-8829-7FDA05D6ABDEQ33722146-DD468C5E-4843-4E04-BB2C-F085AAF8B097Q33980346-AC5B39AE-5CA3-4991-8056-F582AEA6A2FFQ34252344-046C204D-90D2-4889-88EB-9BD85067A429Q35013830-0B1666FE-560F-4D21-8F6C-EDFAA657C355Q35102928-31B924E7-6CBC-42AA-A6CA-D5269B7E9840Q35108009-F12B5EB3-63B5-4066-86B5-C5B0A8EB2789Q35621623-2B51E907-DE5C-49A2-950D-7D065AE4E1A0Q36565896-092AB413-5AC3-4A92-A921-D7E0A10A6BB3Q36568724-6CE76964-828F-447B-86A6-D218F3820B0AQ36667129-70360EF2-1FBB-470A-A3CF-785F9B2FC3F8Q37059284-EC5616B7-88FB-4B0B-B7CF-1EB189E0E221Q37142225-5DA546A1-816C-4223-B5CF-B2BDF41AA5DFQ37292037-2AAF104D-EC08-4A2F-B1A4-1EEA97FFC95BQ37309142-3BA05368-18B9-4AD7-A8BE-7A8D3E391BDEQ37333166-A3A222FF-D5DB-4DCB-81D8-8A176A081B28Q37340339-51EF9961-B0FE-4239-AB74-45850D47E633Q37378899-D3FBC14E-E608-402B-8B7D-11A65B78A97FQ37576098-C1EF494B-6BE7-40E6-965D-6D286B41380CQ37948164-1CFB15D3-BBB3-4232-85F1-4F53ADC7DB92Q38052634-41BCDD76-C85D-44E5-8878-76CCCAC48491Q38235943-51B24A1D-4435-41B1-9AF4-20890639D812Q38238745-CE157A92-4E70-4C0E-AFBA-55BE48EE4F0FQ38621376-98F75F1B-20C5-40B4-80D7-B7EDE475E35CQ39476728-F4A14195-19E6-4BD0-9301-9C8470BEB161Q39652689-5940C427-4FA0-435E-B5A5-E024059DEDA4Q39671183-33C25715-3072-45F2-B1C6-FC59B3820CE3Q39954505-62A5B82E-4D56-4A25-9DEA-9C9CD8080F60Q40345414-17B1A0EB-6C28-495A-99AF-50AC8E97BE19Q40742547-71EB8550-8A27-4374-BAAF-D5D7B814D867Q42033124-DBC95DA2-7595-4859-8A5D-8DFC2679B82FQ42112320-B58F669A-F954-4466-B765-028545FB8635Q42112374-25A4971F-325E-45FF-829C-65456CE0197DQ42735860-5E2BC7B6-616A-476C-ADAA-2A0E29B5AA17Q43708032-B686F81D-2344-49E4-AB7B-685046D4AAF4Q43910711-9C0379FE-5417-4958-AC8E-C3D0E6E40ADDQ44186926-AA2130A2-7CCF-4C7F-A44C-374A5FEED6AC
P2860
Prevalence of Helicobacter pylori resistance to metronidazole, clarithromycin, amoxycillin, tetracycline and trovafloxacin in The Netherlands.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年学术文章
@wuu
1999年学术文章
@zh-cn
1999年学术文章
@zh-hans
1999年学术文章
@zh-my
1999年学术文章
@zh-sg
1999年學術文章
@yue
1999年學術文章
@zh
1999年學術文章
@zh-hant
name
Prevalence of Helicobacter pyl ...... vafloxacin in The Netherlands.
@en
Prevalence of Helicobacter pyl ...... vafloxacin in The Netherlands.
@nl
type
label
Prevalence of Helicobacter pyl ...... vafloxacin in The Netherlands.
@en
Prevalence of Helicobacter pyl ...... vafloxacin in The Netherlands.
@nl
prefLabel
Prevalence of Helicobacter pyl ...... vafloxacin in The Netherlands.
@en
Prevalence of Helicobacter pyl ...... vafloxacin in The Netherlands.
@nl
P2093
P356
P1476
Prevalence of Helicobacter pyl ...... vafloxacin in The Netherlands.
@en
P2093
Debets-Ossenkopp YJ
Herscheid AJ
Kuipers EJ
Kusters JG
Vandenbroucke-Grauls CM
P304
P356
10.1093/JAC/43.4.511
P407
P577
1999-04-01T00:00:00Z